Bilcare Intrinsic Value
Bilcare (BI) median intrinsic value is ₹148.18 from 9 valuation models (range ₹119–₹178), vs current price ₹59.27 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Analyse BI shareholder distribution to track promoter, FII and institutional holdings.
BI Valuation Methods Summary — DCF, Graham Number & P/E
Bilcare intrinsic value across 9 models vs current price ₹59.27 — upside/downside and value range per method. Read BI dividend payout details for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹177.81 | ₹142.25 - ₹213.37 | +200.0% | EPS: ₹22.72, Sector P/E: 22x |
| Book Value Method | asset | ₹148.18 | ₹133.36 - ₹163.00 | +150.0% | Book Value/Share: ₹82.08, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹118.54 | ₹106.69 - ₹130.39 | +100.0% | Revenue/Share: ₹336.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹118.54 | ₹106.69 - ₹130.39 | +100.0% | EBITDA: ₹116.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹148.18 | ₹118.54 - ₹177.82 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹145.41 | ₹130.87 - ₹159.95 | +145.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹177.81 | ₹160.03 - ₹195.59 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹118.54 | ₹106.69 - ₹130.39 | +100.0% | ROE: 16.2%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹164.17 | ₹147.75 - ₹180.59 | +177.0% | EPS: ₹22.72, BVPS: ₹82.08 |
BI Intrinsic Value vs Market Price — All Valuation Models
Bilcare fair value range ₹119–₹178 vs current market price ₹59.27 across 9 valuation models. For current market price and key ratios, visit Bilcare share price screener.
BI Intrinsic Value Analysis — Undervalued or Overvalued?
Bilcare median intrinsic value ₹148.18, current price ₹59.27 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of BI?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bilcare (BI) is ₹148.18 (median value). With the current market price of ₹59.27, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹118.54 to ₹177.81, indicating ₹118.54 - ₹177.81.
Is BI undervalued or overvalued?
Based on our multi-method analysis, Bilcare (BI) appears to be trading below calculated value by approximately 150.0%.
BI Financial Health — Key Ratios vs Industry Benchmarks
Bilcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.74 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 16.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.96x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BI Cash Flow Quality — Operating & Free Cash Flow
Bilcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹63 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹41 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹72 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹256 Cr | ₹256 Cr | Positive Free Cash Flow | 8/10 |